Complete Freund's Adjuvant
Complete Freund's Adjuvant - Related Videos
03:29
A Technique to Generate an Adjuvant-Induced Arthritis Mouse Model
0 Views •
2025
This video demonstrates a method to generate adjuvant-induced arthritis in a murine model. Complete Freund's adjuvant (CFA) is injected in the mouse ankle joint and periarticular areas. CFA activates the immune system, leading to neutrophil infiltration and exaggerated inflammation.
01:50
Preparation of a Nanoemulsion Adjuvant Vaccine
0 Views •
2025
This video demonstrates the production of nanoemulsion tumor vaccines. The stable oil reservoir depots carrying synthetic peptides and adjuvants are produced by low-energy nanoemulsion, offering significant promise for tumor immunotherapy.
04:08
Preparing an Antigen-Adjuvant Emulsion to Induce Autoimmune Encephalomyelitis
0 Views •
2025
This video demonstrates an efficient homogenization technique to generate an antigen-adjuvant emulsion to induce experimental autoimmune encephalomyelitis (EAE) in a murine model. The emulsion contains an autoantigen — myelin oligodendrocyte glycoprotein (MOG) — in the water phase, surrounded by a continuous oil phase comprising an inactivated pathogenic bacteria. The emulsion ensures a sustained release of antigens for a prolonged immune response.
04:13
An Adjuvant Therapy in a Mouse Model with an Incompletely Resected Subcutaneous Tumor
0 Views •
2025
This video illustrates testing of adjuvant or additional therapy in a mouse model with incompletely resected subcutaneous tumors. The partially tumor-resected mouse is treated with an antibody targeting the anti-cytotoxic protein of T regulatory cells, potentially reducing tumor regrowth and suggesting effective adjuvant therapy.
04:45
An Immunological Technique to Monitor Adjuvant-Mediated Cytotoxic T Lymphocyte Generation
0 Views •
2025
The video demonstrates an immunological method to monitor in vivo adjuvant-induced cytotoxic T lymphocyte or CTL production. A mouse is pre-injected with genetically engineered, proliferative dye-stained donor CD8+ T lymphocytes. Subcutaneous injection of ovalbumin with adjuvants generates cytotoxic CD8+ T lymphocytes that are identified post-harvesting through immunostaining and flow cytometry.
FAQs
The mineral-oil phase and inactivated mycobacterial components contribute different but complementary effects. Mineral oil helps retain antigen locally, whereas the mycobacterial material stimulates innate immune pathways. Together, these features increase the opportunity for antigen uptake and presentation, linking early inflammatory signals with stronger antigen-specific responses in experimental animal models.
Formation of a water-in-oil emulsion affects where the antigen remains after administration and how it is encountered by immune cells. The local depot can prolong antigen availability, while innate stimulation supports uptake and presentation. This combination helps explain why CFA can generate robust responses, but also why the injection site may develop substantial inflammation.
CFA can support both cellular and humoral immunity rather than selectively amplifying only one arm. Enhanced antigen presentation helps activate antigen-specific cellular responses, while the same immunization can also promote antibody-related responses. This breadth makes it useful when experiments examine host defense, hypersensitivity, autoimmune disease, or vaccine-related immune principles.
Limiting CFA to primary immunization reflects its inflammatory potential, not a lack of immunological activity. Repeated booster use can add local tissue injury to an already strong inflammatory setting, complicating animal welfare and interpretation of immune results. For this reason, experimental designs generally reserve CFA for the initial exposure and handle later immunization stages more cautiously.
Preparation centers on formulating the experimental antigen with the mineral-oil and inactivated-mycobacterial components so the resulting water-in-oil emulsion can provide both depot behavior and innate stimulation. Researchers then select the animal-model design and immunization schedule with the expected immune response and local reactogenicity in mind, especially avoiding routine repeated CFA exposure.
Use of CFA is especially informative when a study needs a pronounced immune response to a defined experimental antigen. In immunology and infection research, it can support investigations of host responses and vaccine principles; in related disease models, the resulting cellular and humoral activity helps examine hypersensitivity and autoimmune disease. Its inflammatory effects must remain part of interpretation.